University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Kirk Jones, M.D.

Pathologist

Dr. Kirk Jones is a pathologist in surgical pathology and cytopathology. Pathology is the study of disease and involves examining tissue removed during surgery or biopsy to make diagnoses and guide patient care. Jones has a special expertise in pulmonary, or lung, pathology and is responsible for the examining all tissue biopsies for UCSF's Interstitial Lung Disease Program. He also examines lungs removed during surgery for the lung transplant program, and evaluates all post-transplant lung biopsies for signs of infection or rejection of the transplanted lung. He is the primary pathologist for the Thoracic Interdisciplinary Tumor Board and an associate professor of pathology at the UCSF School of Medicine.

Jones earned a medical degree at UCSF and did a combined residency here, in anatomic pathology and laboratory medicine. His fellowship in cytopatholgy was also completed at UCSF. After his fellowship, he was a visiting scholar at the Mayo Clinic in Scottsdale, Ariz., where he studied pulmonary pathology with Dr. Thomas V. Colby and Dr. Kevin O. Leslie. He is a member of the United States and Canadian Academy of Pathology, Pulmonary Pathology Society, International Association for the Study of Lung Cancer, College of American Pathologists and South Bay Pathology Society.

Clinics

Fine Needle Aspiration Biopsy Clinic
1600 Divisadero St., Suite 200
San Francisco, CA 94143
Phone: (415) 353-7043
Fax: (415) 353-7676

Hours: Monday to Friday
9:30 a.m. – 5 p.m.

Interstitial Lung Disease Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-2577
Fax: (415) 353-2568

Hours: Friday
8 a.m. – noon

Conditions & Treatments

More about Kirk Jones

Education

UCSF 1994

Residencies

UCSF, Anatomic Pathology and Laboratory Medicine 1998

Fellowships

UCSF, Surgical pathology and cytopathology 1999

Selected Research and Publications

  1. Woodard GA, Gubens MA, Jahan TM, Jones KD, Kukreja J, Theodore PR, Cardozo S, Jew G, Clary-Macy C, Jablons DM, Mann MJ. Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancer. Clin Lung Cancer. 2014 Nov; 15(6):426-32.
  2. Greenland JR, Xu X, Sayah DM, Liu FC, Jones KD, Looney MR, Caughey GH. Mast cells in a murine lung ischemia-reperfusion model of primary graft dysfunction. Respir Res. 2014; 15(1):95.
  3. Stuart BD, Lee JS, Kozlitina J, Noth I, Devine MS, Glazer CS, Torres F, Kaza V, Girod CE, Jones KD, Elicker BM, Ma SF, Vij R, Collard HR, Wolters PJ, Garcia CK. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. Lancet Respir Med. 2014 Jul; 2(7):557-65.
  4. Ley B, Elicker BM, Hartman TE, Ryerson CJ, Vittinghoff E, Ryu JH, Lee JS, Jones KD, Richeldi L, King TE, Collard HR. Idiopathic Pulmonary Fibrosis: CT and Risk of Death. Radiology. 2014 Nov; 273(2):570-9.
  5. Lubin M, Chen H, Elicker B, Jones KD, Collard HR, Lee JS. A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. Chest. 2014 Jun 1; 145(6):1333-8.
  6. Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE, Collard HR. Predicting Survival Across Chronic Interstitial Lung Disease: The ILD-GAP Model. Chest. 2014 Apr 1; 145(4):723-8.
  7. Urisman A, Jones KD. Pulmonary pathology in connective tissue disease. Semin Respir Crit Care Med. 2014 Apr; 35(2):201-12.
  8. Barcia SM, Kukreja J, Jones KD. Pulmonary interstitial emphysema in adults: a clinicopathologic study of 53 lung explants. Am J Surg Pathol. 2014 Mar; 38(3):339-45.
  9. Lim L, Balakrishnan A, Huskey N, Jones KD, Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, Willenbring H, Dupuy A, Chen X, Brown D, Chang AN, Goga A. MicroRNA-494 within an oncogenic microRNA megacluster regulates G1 /S transition in liver tumorigenesis through suppression of mutated in colorectal cancer. Hepatology. 2014 Jan; 59(1):202-15.
  10. Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 2014 Jan 24; 9:157-79.
  11. Hosgood HD, Pao W, Rothman N, Hu W, Pan YH, Kuchinsky K, Jones KD, Xu J, Vermeulen R, Simko J, Lan Q. Driver mutations among never smoking female lung cancer tissues in China identify unique EGFR and KRAS mutation pattern associated with household coal burning. Respir Med. 2013 Nov; 107(11):1755-62.
  12. Jones KD. Whence lepidic?: the history of a canadian neologism. Arch Pathol Lab Med. 2013 Dec; 137(12):1822-4.
  13. Mooney JJ, Elicker BM, Urbania TH, Agarwal MR, Ryerson CJ, Nguyen ML, Woodruff PG, Jones KD, Collard HR, King TE, Koth LL. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest. 2013 Aug; 144(2):586-92.
  14. Jones KD, Churg A, Henderson DW, Hwang DM, Wyatt JM, Nicholson AG, Rice AJ, Washington MK, Butnor KJ. Data set for reporting of lung carcinomas: recommendations from International Collaboration on Cancer Reporting. Arch Pathol Lab Med. 2013 Aug; 137(8):1054-62.
  15. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE, Ryu J, Collard HR. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013 Jul; 144(1):234-40.
  16. Greenland JR, Jones KD, Hays SR, Golden JA, Urisman A, Jewell NP, Caughey GH, Trivedi NN. Association of large-airway lymphocytic bronchitis with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2013 Feb 15; 187(4):417-23.
  17. Doyon JB, Sutton DA, Theodore P, Dhillon G, Jones KD, Thompson EH, Fu J, Wickes BL, Koehler JE, Schwartz BS. Rasamsonia argillacea pulmonary and aortic graft infection in an immune-competent patient. J Clin Microbiol. 2013 Feb; 51(2):719-22.
  18. Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2013 Sep; 42(3):750-7.
  19. Lee JS, Kim EJ, Lynch KL, Elicker B, Ryerson CJ, Katsumoto TR, Shum AK, Wolters PJ, Cerri S, Richeldi L, Jones KD, King TE, Collard HR. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med. 2013 Feb; 107(2):249-55.
  20. Cha SI, Ryerson CJ, Lee JS, Kukreja J, Barry SS, Jones KD, Elicker BM, Kim DS, Papa FR, Collard HR, Wolters PJ. Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis. Respir Res. 2012; 13:105.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.